Study Offers Way to Increase Immune Checkpoint Inhibitor Effectiveness in Patients With MTAP-Deleted Cancers
Loss of the “housekeeping” gene methylthioadenosine phosphorylase, or MTAP, is a common event in cancer.
Stay updated with breaking news from Elio Adib. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Loss of the “housekeeping” gene methylthioadenosine phosphorylase, or MTAP, is a common event in cancer.
A new, bio-inspired drug restores the effectiveness of immune cells in fighting cancer, a team led by researchers at The University of Texas at Austin has found.
The study offers insights on a medication that can boost immunotherapy's effect and restore the ability of the immune system in fighting tumors. | Health
AUSTIN, Texas — A new, bio-inspired drug restores the effectiveness of immune cells in fighting cancer, a team led by researchers at The University of
In mouse models of different cancers, a new drug slowed tumor growth, extended lifespan, and boosted the efficacy of immunotherapy.